Sio Gene Therapies Inc
(SIOX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -129,065 | -120,019 | -85,723 | -51,888 | -221,573 |
| Depreciation Amortization | 2,450 | 2,123 | 1,647 | 1,034 | 3,083 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 2,709 |
| Accounts payable and accrued liabilities | -2,251 | -2,931 | -2,132 | -2,518 | -4,602 |
| Other Working Capital | -19,083 | -18,150 | -13,842 | -16,977 | -6,217 |
| Other Operating Activity | 13,742 | 16,353 | 10,903 | 8,936 | 36,252 |
| Operating Cash Flow | $-134,207 | $-122,624 | $-89,147 | $-61,413 | $-190,348 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -202 | -74 | -18 | N/A | -4,284 |
| Investing Cash Flow | $-202 | $-74 | $-18 | $N/A | $-4,284 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -9,707 | -4,780 | N/A | N/A | N/A |
| Common Stock Issued | 335 | 293 | 118 | 10 | 1,557 |
| Other Financing Activity | 96,443 | 57,787 | 25,436 | 0 | 134,839 |
| Financing Cash Flow | $87,071 | $53,300 | $25,554 | $10 | $136,396 |
| Beginning Cash Position | 154,337 | 154,337 | 154,337 | 154,337 | 212,573 |
| End Cash Position | 106,999 | 84,939 | 90,726 | 92,934 | 154,337 |
| Net Cash Flow | $-47,338 | $-69,398 | $-63,611 | $-61,403 | $-58,236 |
| Free Cash Flow | |||||
| Operating Cash Flow | -134,207 | -122,624 | -89,147 | -61,413 | -190,348 |
| Capital Expenditure | -202 | -74 | -18 | N/A | -4,284 |
| Free Cash Flow | -134,409 | -122,698 | -89,165 | -61,413 | -194,632 |